Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study

NCT07121374 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT07121374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
Lead sponsor
University Hospital, Antwerp
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 22, 2025
Completion date
July 31, 2029
Enrollment
37 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma; pleura, neoadjuvant chemoimmunotherapy, pleural epithelioid mesothelioma